EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan

Mariko Miki iD, Yo Shimazu, Ryo Daniel Obara, Takashi Nagamine, Yumiko Nakaya, Yoshinori Ikenaka, Hiromi Osaki, Takashi Kimura, Takahiro Hiono, Norikazu Isoda, Takao Shishido iD, Yoshihiro Sakoda

PLOS One · 23.03.2026 · 21 (3) · e0345055

DOI: 10.1371/journal.pone.0345055 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, online erschienen am 23.03.2026. Verfasst von Mariko Miki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan. Hauptthemen laut MEDLINE: Antiviral Agents, Endangered Species, Influenza in Birds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of the Environment, Government of Japan, Shionogi, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High pathogenicity avian influenza (HPAI) is a highly infectious and lethal disease of birds that causes systemic symptoms and has been spreading globally, including in Japan. The Okinawa rail ( Hypotaenidia okinawae ), a flightless bird endemic to Japan, is classified as an endangered species on the Red List. In 2004, the Ministry of the Environment of Japan began implementing a conservation breeding program for Okinawa rails, focusing on maintaining the species’ genetic diversity, captive breeding, and reintroduction to the wild. Given the potential for significant losses due to HPAI in Okinawa rails, the establishment of a treatment protocol as a preparedness measure is essential. The aim of this study was to determine an appropriate treatment method for HPAI in Okinawa rails using baloxavir marboxil (BXM), a drug shown to be effective in an avian laboratory model of HPAI virus infection. Single oral administration of BXM at 2.5 or 12.5 mg/kg did not produce plasma concentrations sufficient to achieve the expected therapeutic efficacy. Therefore, oral administration was deemed inadequate for generating the desired pharmacological effects. Consequently, subcutaneous administration of BXM to Okinawa rails at a dose of 2.5 or 7.5 mg/kg was explored as an alternative protocol, which resulted in higher systemic exposure compared with oral administration. Furthermore, plasma concentrations were maintained at therapeutically relevant levels up to 24 hours after subcutaneous administration at 7.5 mg/kg, with mild and reversible injection site irritation the main adverse effect. Based on these results, subcutaneous administration of BXM is proposed as a viable treatment protocol for HPAI in the conservation of endangered Okinawa rails.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsEndangered SpeciesInfluenza in BirdsAnimalsFemaleMaleAdministration, OralBirdsChickensDibenzothiepinsInjections, SubcutaneousJapanMorpholinesPyridonesRandom AllocationTriazines

Substanzen

Antiviral AgentsbaloxavirDibenzothiepinsMorpholinesPyridonesTriazines

Autor:innen und Institutionen

  • Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan.
  • Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Okinawa Wildlife Federation, Uruma, Okinawa, Japan.
  • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
  • Water Research Group, School of Environmental Sciences and Development, North-West University, Potchefstroom, South Africa.
  • Translational Research Unit, Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.

ORCID-Profile: Mariko Miki, Takao Shishido

Förderung

  • Ministry of the Environment, Government of Japan
  • Shionogi
  • Japan Agency for Medical Research and Development

Zitieren

APA

Miki, M., Shimazu, Y., Obara, R. D., Nagamine, T., Nakaya, Y., Ikenaka, Y., Osaki, H., Kimura, T., Hiono, T., Isoda, N., Shishido, T., & Sakoda, Y. (2026). Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan. PLOS One, 21(3), e0345055. https://doi.org/10.1371/journal.pone.0345055

Vancouver

Miki M, Shimazu Y, Obara RD, Nagamine T, Nakaya Y, Ikenaka Y, et al. Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan. PLOS One. 2026;21(3):e0345055. doi:10.1371/journal.pone.0345055

BibTeX
@article{Miki2026,
  author = {Miki, Mariko and Shimazu, Yo and Obara, Ryo Daniel and Nagamine, Takashi and Nakaya, Yumiko and Ikenaka, Yoshinori and Osaki, Hiromi and Kimura, Takashi and Hiono, Takahiro and Isoda, Norikazu and Shishido, Takao and Sakoda, Yoshihiro},
  title = {Assessment of a baloxavir marboxil treatment protocol for high pathogenicity avian influenza in Okinawa Rails, an endangered species endemic to Japan},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0345055},
  doi = {10.1371/journal.pone.0345055}
}
Kostenlos starten →